Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug treatment of acute leukaemia. Current status.

Literature DB >> 2667939

Drug treatment of acute leukaemia. Current status.

Abstract

The drug treatment of acute leukaemia has changed considerably over the past years, offering the possibility of remission and, in some cases, cure. The broad outline of treatment schedules, the drugs in current use and newer approaches to therapy are discussed. Bone marrow transplantation is described in brief, as well as the role of support therapy.

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 1989 PMID： 2667939 DOI： 10.2165/00003495-198937060-00006

Source DB: PubMed Journal: Drugs ISSN： 0012-6667 Impact factor: 9.546

Keyword Cloud
References

47 in total

1. Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults.

Authors: S M Donohue; B J Boughton
Journal: Cancer Chemother Pharmacol Date: 1989 Impact factor: 3.333

2. Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

Authors: E D Thomas; C D Buckner; R A Clift; A Fefer; F L Johnson; P E Neiman; G E Sale; J E Sanders; J W Singer; H Shulman; R Storb; P L Weiden
Journal: N Engl J Med Date: 1979-09-13 Impact factor: 91.245

3. Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma.

Authors: O Kucuk; H C Kwaan; W Gunnar; R M Vazquez
Journal: Cancer Date: 1985-02-15 Impact factor: 6.860

10. Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy.

Authors: R E Champlin; W G Ho; R P Gale; D Winston; M Selch; R Mitsuyasu; C Lenarsky; R Elashoff; J Zighelboim; S A Feig
Journal: Ann Intern Med Date: 1985-03 Impact factor: 25.391

Drug treatment of acute leukaemia. Current status.

1. Fractionated anthracycline therapy in acute myeloblastic leukaemia in adults.

2. Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

3. Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma.

Review 4. The anthracycline antineoplastic drugs.

Review 5. Acute myeloid leukaemia: recent advances in therapy.

6. Risk factors for doxorubicin-induced congestive heart failure.

7. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization.

8. Phase I-II study of piperazinedione in adults with solid tumors and acute leukemia.

9. Growth in children treated for acute lymphoblastic leukaemia.

10. Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy.